BioSpace News Archive

Titan Medical Inc. announced today that it has signed a manufacturing and supply agreement with Benchmark Electronics, Inc. (NYSE: BHE) to produce Titan’s innovative Enos™ robotic single access surgical system workstations and patient carts.

Phio Pharmaceuticals Corp. today announced that it has received regulatory clearance to start a clinical trial with its lead product candidate, PH-762.

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, expanded on the information provided Monday at the H.C. Wainwright BioConnect Virtual Conference regarding the BriLife™ investigational vaccine for COVID-19.

Cabaletta Bio, Inc. today announced the promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D. to Chief Business Officer.

Oryzon Genomics, S.A. announced that Dr. Ana Limón has been appointed as Senior Vice President of Clinical Development and Global Medical Affairs.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), and Antion Biosciences, today announced that they have entered into an exclusive collaboration and global license agreement for Antion’s miRNA technology (miCAR™) to advance multiplex gene silencing as an additional tool to develop next generation allogeneic CAR T products.

Harpoon Therapeutics, Inc. today provided a pipeline milestone update on its TriTAC development programs.

Fluidigm Corporation announced preliminary revenue for the fourth quarter and full year ended December 31, 2021, exceeding the company’s guidance for those periods.

Global workplace strategy, design and construction firm Unispace announced its acquisition of BioPharma Engineering, an Ireland-based firm that designs and delivers laboratory, research and manufacturing facility space for the life sciences industry.

Cardiff Oncology, Inc. today announced the appointments of Tod Smeal, Ph.D., as chief scientific officer (CSO) and Charles Monahan, RPh, as senior vice president, regulatory affairs.